» Articles » PMID: 34626592

There is No "origin" to SARS-CoV-2

Overview
Journal Environ Res
Publisher Elsevier
Date 2021 Oct 9
PMID 34626592
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Since the beginning of the COVID-19 pandemic in 2020 caused by SARS-CoV-2, the question of the origin of this virus has been a highly debated issue. Debates have been, and are still, very disputed and often violent between the two main hypotheses: a natural origin through the "spillover" model or a laboratory-leak origin. Tenants of these two options are building arguments often based on the discrepancies of the other theory. The main problem is that it is the initial question of the origin itself which is biased. Charles Darwin demonstrated in 1859 that all species are appearing through a process of evolution, adaptation and selection. There is no determined origin to any animal or plant species, simply an evolutionary and selective process in which chance and environment play a key role. The very same is true for viruses. There is no determined origin to viruses, simply also an evolutionary and selective process in which chance and environment play a key role. However, in the case of viruses the process is slightly more complex because the "environment" is another living organism. Pandemic viruses already circulate in humans prior to the emergence of a disease. They are simply not capable of triggering an epidemic yet. They must evolve in-host, i.e. in-humans, for that. The evolutionary process which gave rise to SARS-CoV-2 is still ongoing with regular emergence of novel variants more adapted than the previous ones. The real relevant question is how these viruses can emerge as pandemic viruses and what the society can do to prevent the future emergence of pandemic viruses.

Citing Articles

Bat Ecology and Microbiome of the Gut: A Narrative Review of Associated Potentials in Emerging and Zoonotic Diseases.

Bazzoni E, Cacciotto C, Zobba R, Pittau M, Martella V, Alberti A Animals (Basel). 2024; 14(20).

PMID: 39457973 PMC: 11504201. DOI: 10.3390/ani14203043.


Emergence of crucial evidence catalyzing the origin tracing of SARS-CoV-2.

Chen S, Ruan C, Guo Y, Chang J, Yan H, Chen L PLoS One. 2024; 19(8):e0309557.

PMID: 39213297 PMC: 11364235. DOI: 10.1371/journal.pone.0309557.


New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.

Carvajal J, Garcia-Castillo V, Cuellar S, Campillay-Veliz C, Salazar-Ardiles C, Avellaneda A Front Immunol. 2024; 15:1363572.

PMID: 38911850 PMC: 11190347. DOI: 10.3389/fimmu.2024.1363572.


Updated analysis to reject the laboratory-engineering hypothesis of SARS-CoV-2.

Wu F Environ Res. 2023; 224:115481.

PMID: 36804316 PMC: 9937728. DOI: 10.1016/j.envres.2023.115481.


Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2.

Chavda V, Mishra T, Vuppu S Vaccines (Basel). 2023; 11(1).

PMID: 36679891 PMC: 9867374. DOI: 10.3390/vaccines11010045.


References
1.
Steverding D . The spreading of parasites by human migratory activities. Virulence. 2020; 11(1):1177-1191. PMC: 7549983. DOI: 10.1080/21505594.2020.1809963. View

2.
Ge X, Wang N, Zhang W, Hu B, Li B, Zhang Y . Coexistence of multiple coronaviruses in several bat colonies in an abandoned mineshaft. Virol Sin. 2016; 31(1):31-40. PMC: 7090819. DOI: 10.1007/s12250-016-3713-9. View

3.
Devaux C, Pinault L, Omar Osman I, Raoult D . Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?. Front Public Health. 2021; 8:608765. PMC: 7902720. DOI: 10.3389/fpubh.2020.608765. View

4.
Hartfield M, Alizon S . Introducing the outbreak threshold in epidemiology. PLoS Pathog. 2013; 9(6):e1003277. PMC: 3680036. DOI: 10.1371/journal.ppat.1003277. View

5.
Zhou B, Thao T, Hoffmann D, Taddeo A, Ebert N, Labroussaa F . SARS-CoV-2 spike D614G change enhances replication and transmission. Nature. 2021; 592(7852):122-127. DOI: 10.1038/s41586-021-03361-1. View